RISTOVA (Rituximab) is a monoclonal antibody that works by targeting the CD20 antigen on normal and malignant B-cells. Then the body’s natural immune defenses are recruited to attack and kill the marked B-cells.
Ristova is used for the treatment of several different conditions in adults such as:
Non-hodgkin’s lymphoma (NHL)
Chronic lymphocytic leukemia
Granulomatosis with polyangiitis or microscopic polyangiitis